The Scientific Research Team at Recludix Pharma is responsible for discovering and developing potent and selective inhibitors for challenging protein targets. Leveraging DNA-encoded libraries, structure-activity relationship determination, and proprietary screening tools, the team works collaboratively on medicinal chemistry, immunobiology, and in vivo pharmacology to drive innovative therapeutic solutions.
Angelo Moreno
Scientist In Vivo Pharmacology
Donglim Esther Park
Senior Scientist
Howie Bregman
Sr. Director of Medicinal Chem...
Jessica Ma
Senior Associate Scientist
John Yeoman
Senior Principal Scientist, Me...
Ksenya Cohen Katsene...
Principal Scientist
Neil Bifulco
Director of Medicinal Chemistr...
Patrick Metz
Associate Director, Immunobiol...
Samuel Reznik
Director of Medicinal Chemistr...
Travis Grant
Associate Scientist
View all